Life Science Services

Companies Set-Up

One-Stop Shop to set up subsidiaries in Switzerland and Europe.

Life Science Services can support you with the following:

Due Diligence

Due Diligence

Key considerations for incorporation of a subsidiary:

• Intellectual Property (IP) planning

• Transfert Pricing and arm's length principle 

• Tax considerations - permanent establishement (PE) risk, value added tax (VAT) and custom duties. Mitigate risks for double taxation

• Compliance and reporting.



You can set up a company in no more than 3 working days, and for a capital cost starting at EUR 100.

People Resources

People Resources

We provide support to your international employees and team members under various forms:

• Payroll company

• Interim management solutions

  • FTE for a limited period of time

• Management consulting solutions

  •Project managers & advisors to manage and mentor your project.

The prerequisite for a life sciences company to request the Marketing Authorisation Holder (MAH) with the European Medicines Agency (EMA) is to have a permanent establishment within a country of the European Union. The EMA requires proof of establishment and failing to comply can delay the application.

In the past, it was enough to appoint a representative, however the latest international policies, both from a drug regulatory as well as financial regulations, make it more complex because of the possible liabilities when a company fail to comply with the rules.

What is the appropriate infrastructure and business process? Looking from the US, the European Biotech “places to be” seems very fragmented!

Every country has its own ranking: if Switzerland is the leading country for patents, mostly because of advantageous IP Box fiscal structure, academics cooperation and grants are relatively poor compared to UK and Germany. Spain, Catalonia, is the place to be for Digital Health & Big Data, Biomedical Sciences and Genomics, and offers good access to capital and tax incentives too!

It is therefore very important to think carefully where to establish first, as it will be determinant for the future of the European operations, including the companies and tax structure.